Reimbursement Considerations in Product Commercialization - MCRA Webinar

Описание: Market Access and Reimbursement are often overlooked when a product is being brought to market. Unfortunately, this can result in numerous issues and delays in the adoption process for a new technology. By taking early action, companies can avoid many problems which can limit their uptake in the market.

In this webinar, MCRA experts Michael Anselmo, John Schmitt, Anne O'Brien and Nicole Fitzpatrick discuss why a well timed and thought-out market access strategy aids companies in accelerating their sales and product adoption in the healthcare environment.

Webinar hosted by MCRA.

---------------------------------------------------------
MCRA is the leading therapy focused global full-service medical device, diagnostics & biologics CRO & consulting advisory firm.

MCRA is the pioneer and leader in integrating its core service offerings to bring healthcare innovation to the market globally, from conception to commercialization.

Our team of industry leading talent, including former FDA reviewers, notified body decision makers, clinical subject matter experts, reimbursement veterans and payers, provides in-depth therapeutic knowledge and thorough market understanding to each project we take.

MCRA's Service Offerings:
Full Service Clinical Research Organization
Global Regulatory Support
US Regulatory Support
Reimbursement, Healthcare Economics & Market Access
Quality Assurance & Quality Operations
Healthcare Compliance
Cybersecurity
Due Diligence
AI & Imaging Center
Talent Solutions

Learn more about MCRA at www.mcra.com.